Business modelsB2B

Products 141 to 150 of 162

Solein by Solar Foods
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:34 (3 years ago)
Date last modified: 2020/12/18 14:34 (3 years ago)
Known funding amount: 18,500,000
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Feed
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input + Platform
Sorona by DuPont + Tate & Lyle Bio Products
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: North America + China + South Korea
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
SOS-Chromotest by Environmental Bio-Detection Products, Inc.
Biotech components: Bacteria
Business models: B2B
Country of production: Canada
Country of distribution: Canada
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Science
Market status: On the market
Organization type(s): Private Company
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Spider Pillar by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA + Vietnam
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 5,000,000 USD
Funding types: Government + Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Web search
Trading symbol: KBLB (OTCMKTS)
Value chain stage: Input
Stevia by Evolva
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 37,000,000 USD
Funding types: University + Government
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Susterra by DuPont + Tate & Lyle Bio Products
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
SYN-004 (RIBAXAMASE) by Synthetic Biologics
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 12,467,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
SYN-005 by Synthetic Biologics + Intrexon
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:27 (6 years ago)
Known funding amount: 24,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
Synbio Lantibiotics by University of Groningen
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Health
Market status: More information needed + Under Development
Organization type(s): University
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input